Autologous Platelet-Rich Plasma in the Treatment of Perianal Fistula in Crohn’s Disease
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 24 (12) , 2814-2821
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trialInternational Journal of Colorectal Disease, 2012
- Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal CellsStem Cells and Development, 2012
- Quality of Life in Perianal Crohn's Disease: What Do Patients Consider Important?Diseases of the Colon & Rectum, 2011
- Autologous platelet-derived growth factors (platelet-rich plasma) as an adjunct to mucosal advancement flap in high cryptoglandular perianal fistulae: a pilot studyColorectal Disease, 2011
- Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal FistulaDiseases of the Colon & Rectum, 2009
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Autologous platelets as a source of proteins for healing and tissue regenerationThrombosis and Haemostasis, 2004
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity IndexJournal of Clinical Gastroenterology, 1995
- Anorectal Crohn's diseaseDiseases of the Colon & Rectum, 1985